|
|
Article: Derma Sciences Announces Voluntary Delisting from the Defunct Boston Stock Exchange.
- Article from:
- PR Newswire
- Article date:
- May 5, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PRINCETON, N.J., May 5 /PRNewswire-FirstCall/ -- Derma Sciences (OTC Bulletin Board: DSCI), a manufacturer and marketer of advanced wound care products, today announced that it intended to voluntarily delist its common stock, $0.01 par value, from the defunct Boston Stock Exchange and that it would file Form 25 with the Securities and Exchange Commission on or about May 15, 2009 to effect this delisting.
Ed Quilty, CEO of Derma Sciences, noted that, "In October, 2007 Nasdaq acquired the Boston Stock Exchange and immediately terminated the exchange's trading activities. Thus, the delisting is merely a formality and should have no impact whatsoever on the trading ...